<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="134">
  <stage>Registered</stage>
  <submitdate>5/08/2005</submitdate>
  <approvaldate>12/08/2005</approvaldate>
  <actrnumber>ACTRN12605000131651</actrnumber>
  <trial_identification>
    <studytitle>Anaesthesia with propofol/morphine versus anaesthesia with propofol/remifentanil: Differences in Bronchial Mucous Transport Velocity</studytitle>
    <scientifictitle>Bronchoscopic evaluation of bronchial mucus transport velocity: anaesthesia with propofol/morphine versus anaesthesia with propofol/remifentanil</scientifictitle>
    <utrn />
    <trialacronym>BTV3</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Bronchial mucus transport velocity</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Normal development and function of the respiratory system</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Tracheobronchoscopy</interventions>
    <comparator />
    <control />
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The bronchial mucus transport velocity</outcome>
      <timepoint>Bronchoscopically assessed 30 min after placing the endotracheal tube.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>n/a</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>ASA class 1-3; Elective, non-thoracic surgery of expected duration of more than one hour.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>ASA &gt;3, compromised lung function (asthma, CAL, previous lung surgery), smoking, Atopy (hay fever, allergic rhinits), medication that compromises BTV function (beta blockers, steroids, theophylline, catecholamines, atropine).</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/08/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Royal Perth Hospital</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Departmental funding Royal Perth Hospital</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>n/a</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Intraoperative bronchoscopic assessment of bronchial mucus transport velocity in patients having either an anaesthesia with morphine/propofol or remifentanil/propofol.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Perth Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Thomas Ledowski</name>
      <address>Department of Anaesthesia and Pain Medicine
Royal Perth Hospital
Wellington Street
Perth WA 6000</address>
      <phone>+61 8 92242797</phone>
      <fax>+61 8 92241111</fax>
      <email>thomas.ledowski@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Thomas Ledowski</name>
      <address>Department of Anaesthesia and Pain Medicine
Royal Perth Hospital
Wellington Street
Perth WA 6000</address>
      <phone>+61 8 92242797</phone>
      <fax>+61 8 92241111</fax>
      <email>thomas.ledowski@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>